Suberect Spatholobus Tablets
Natural health product licensed in Canada
- Other names
- Jixueteng Tablets
- Licence holder
- Classical Remedia Ltd.
- NPN or DIN-HM
- 80034055
- Status
- Active licence
- Licence date
- 26 July 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Spatholobus suberectus Source : lianoid stem | 200 mg | Not calculated |
| Spatholobus suberectus Source : lianoid stem Extraction ratio : 18:1 Dry plant equivalent : 1,800 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditional Chinese Medicine used to replenish the Blood, unlock and relax the collaterals and tendons. Used in Tradition Chinese Medicine to relieve symptoms associated with Blood-deficiency such as soreness and ache in the back (lumbar) and used for menstrual disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80034055
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.